Primary refractoriness to platelet transfusion caused by Nak(a) antibody alone

Vox Sang. 2001 Jul;81(1):42-4. doi: 10.1046/j.1423-0410.2001.00048.x.

Abstract

Background and objectives: Anti-Nak(a), a platelet-specific antibody, occasionally causes platelet-transfusion refractoriness (PTR) together with human leucocyte antigen (HLA) antibodies. Anti-Nak(a) usually appears after frequent platelet transfusions or pregnancy. We report the first case of PTR caused by anti-Nak(a) alone.

Materials and methods: A 19-year-old male patient with testicular tumour showed PTR when receiving his first transfusion of platelets. Screening for platelet antigens and platelet antibodies revealed that he had type I CD36 (Nak(a)) deficiency and that anti-Nak(a), but not anti-HLA, was present before he received his first transfusion.

Results: The transfusion of Nak(a)-negative, but HLA non-selected, platelets was effective in raising the platelet count.

Conclusion: Clinically significant Nak(a) antibody was present as naturally occurring antibody in a platelet glycoprotein IV (CD36)-negative non-transfused male patient.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antigens, Human Platelet / immunology*
  • Blood Platelets / immunology
  • CD36 Antigens / immunology
  • Humans
  • Isoantibodies / adverse effects*
  • Male
  • Platelet Count
  • Platelet Transfusion / methods*
  • Testicular Neoplasms / therapy

Substances

  • Antigens, Human Platelet
  • CD36 Antigens
  • Isoantibodies
  • Naka isoantigen, human